Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

It forecasts that the repurchases - which are due to complete in 18 months - will boost core earnings by 6% to 8% in 2025 ...

GSK Plc is looking to further grow its cancer drug business, a senior executive said, after the drugmaker’s $1.15 billion ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

Broader markets also mirrored the benchmarks as the Nifty Smallcap100 and Nifty Midcap100 indices ended down by 1.02 per cent ...

Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...

Coming in first on the list of Top 25 Pharma Companies US Rx is AbbVie, reaching $41,857m in US Rx revenue in 2023 and ...

The FTSE 100 index saw an uptick, driven by healthcare and defence stocks, bouncing back from a four-day downturn. BAE ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

Friday’s weak performance by US equities means London’s FTSE 100 index is set for a subdued start to the new week. The FTSE ...